Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

335 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Polymer-Free Drug-Coated Coronary Stents Are Cost-Effective in Patients at High Bleeding Risk: Economic Evaluation of the LEADERS FREE Trial.
Filipovic-Pierucci A, Durand-Zaleski I, Butel T, Greene S, Hovasse T, Iñiguez A, Nazzaro MS, Oldroyd KG, Talwar S, Richardt G, Windhovel U, Urban P, Morice MC. Filipovic-Pierucci A, et al. Among authors: iniguez a. EuroIntervention. 2018 Feb 20;13(14):1688-1695. doi: 10.4244/EIJ-D-17-00286. EuroIntervention. 2018. PMID: 28891471 Free article.
Rationale and design of the EXAMINATION trial: a randomised comparison between everolimus-eluting stents and cobalt-chromium bare-metal stents in ST-elevation myocardial infarction.
Sabaté M, Cequier A, Iñiguez A, Serra A, Hernández-Antolín R, Mainar V, Valgimigli M, Tespili M, den Heijer P, Bethencourt A, Vázquez N, Brugaletta S, Backx B, Serruys P. Sabaté M, et al. Among authors: iniguez a. EuroIntervention. 2011 Dec;7(8):977-84. doi: 10.4244/EIJV7I8A154. EuroIntervention. 2011. PMID: 22115622 Free article. Clinical Trial.
Sirolimus-eluting stent versus bare metal stent in diabetic patients: the final five-year follow-up of the DIABETES trial.
Jiménez-Quevedo P, Hernando L, Gómez-Hospital JA, Iñiguez A, SanRoman A, Alfonso F, Hernández-Antolín R, Angiolillo DJ, Bañuelos C, Escaned J, Gonzalo N, Fernández C, Macaya C, Sabaté M; DIABETES Investigators. Jiménez-Quevedo P, et al. Among authors: iniguez a. EuroIntervention. 2013 Jul;9(3):328-35. doi: 10.4244/EIJV9I3A54. EuroIntervention. 2013. PMID: 23518240 Free article. Clinical Trial.
Predictors of adverse events among patients undergoing primary percutaneous coronary intervention: insights from a pooled analysis of the COMFORTABLE AMI and EXAMINATION trials.
Taniwaki M, Stefanini GG, Räber L, Brugaletta S, Cequier A, Heg D, Iñiguez A, Kelbæk H, Serra A, Ostoijic M, Hernandez-Antolin R, Baumbach A, Blöchlinger S, Jüni P, Mainar V, Sabate M, Windecker S. Taniwaki M, et al. Among authors: iniguez a. EuroIntervention. 2015 Aug;11(4):391-8. doi: 10.4244/EIJY14M07_12. EuroIntervention. 2015. PMID: 25042419 Free article.
Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction: rationale and design of the randomised TROFI II study.
Räber L, Onuma Y, Brugaletta S, Garcia-Garcia HM, Backx B, Iñiguez A, Okkels Jensen L, Cequier-Fillat À, Pilgrim T, Christiansen EH, Hofma SH, Suttorp M, Serruys PW, Sabaté M, Windecker S. Räber L, et al. Among authors: iniguez a. EuroIntervention. 2016 Jul 20;12(4):482-9. doi: 10.4244/EIJY15M08_03. EuroIntervention. 2016. PMID: 26342471 Free article. Clinical Trial.
Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk.
Urban P, Meredith IT, Abizaid A, Pocock SJ, Carrié D, Naber C, Lipiecki J, Richardt G, Iñiguez A, Brunel P, Valdes-Chavarri M, Garot P, Talwar S, Berland J, Abdellaoui M, Eberli F, Oldroyd K, Zambahari R, Gregson J, Greene S, Stoll HP, Morice MC; LEADERS FREE Investigators. Urban P, et al. Among authors: iniguez a. N Engl J Med. 2015 Nov 19;373(21):2038-47. doi: 10.1056/NEJMoa1503943. Epub 2015 Oct 14. N Engl J Med. 2015. PMID: 26466021 Free article. Clinical Trial.
2-Year Outcomes of High Bleeding Risk Patients After Polymer-Free Drug-Coated Stents.
Garot P, Morice MC, Tresukosol D, Pocock SJ, Meredith IT, Abizaid A, Carrié D, Naber C, Iñiguez A, Talwar S, Menown IBA, Christiansen EH, Gregson J, Copt S, Hovasse T, Lurz P, Maillard L, Krackhardt F, Ong P, Byrne J, Redwood S, Windhövel U, Greene S, Stoll HP, Urban P; LEADERS FREE Investigators. Garot P, et al. Among authors: iniguez a. J Am Coll Cardiol. 2017 Jan 17;69(2):162-171. doi: 10.1016/j.jacc.2016.10.009. Epub 2016 Oct 30. J Am Coll Cardiol. 2017. PMID: 27806919 Free article. Clinical Trial.
Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention.
Vaduganathan M, Harrington RA, Stone GW, Deliargyris EN, Steg PG, Gibson CM, Hamm CW, Price MJ, Menozzi A, Prats J, Elkin S, Mahaffey KW, White HD, Bhatt DL; CHAMPION Investigators. Vaduganathan M, et al. J Am Coll Cardiol. 2017 Jan 17;69(2):176-185. doi: 10.1016/j.jacc.2016.10.055. J Am Coll Cardiol. 2017. PMID: 28081827 Free article. Clinical Trial.
Impact of stent overlapping on long-term clinical outcomes in patients with ST-segment elevation myocardial infarction: insights from the five-year follow-up of the EXAMINATION trial.
Ortega-Paz L, Brugaletta S, Giacchi G, Ishida K, Cequier A, Iñiguez A, Serra A, Jiménez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Valgimigli M, Serruys PW, Sabaté M. Ortega-Paz L, et al. Among authors: iniguez a. EuroIntervention. 2017 Aug 4;13(5):e557-e563. doi: 10.4244/EIJ-D-16-00512. EuroIntervention. 2017. PMID: 28242584 Free article.
335 results